JP2023531594A5 - - Google Patents
Info
- Publication number
- JP2023531594A5 JP2023531594A5 JP2022575309A JP2022575309A JP2023531594A5 JP 2023531594 A5 JP2023531594 A5 JP 2023531594A5 JP 2022575309 A JP2022575309 A JP 2022575309A JP 2022575309 A JP2022575309 A JP 2022575309A JP 2023531594 A5 JP2023531594 A5 JP 2023531594A5
- Authority
- JP
- Japan
- Prior art keywords
- ser
- amino acid
- val
- antibody
- leu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026029727A JP2026102638A (ja) | 2020-06-08 | 2026-02-26 | 抗体結合ナノ粒子 |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063036062P | 2020-06-08 | 2020-06-08 | |
| US63/036,062 | 2020-06-08 | ||
| US202063085351P | 2020-09-30 | 2020-09-30 | |
| US63/085,351 | 2020-09-30 | ||
| US202063088586P | 2020-10-07 | 2020-10-07 | |
| US202063088576P | 2020-10-07 | 2020-10-07 | |
| US63/088,576 | 2020-10-07 | ||
| US63/088,586 | 2020-10-07 | ||
| PCT/US2021/036117 WO2021252327A2 (en) | 2020-06-08 | 2021-06-07 | Antibody-bound nanoparticles |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026029727A Division JP2026102638A (ja) | 2020-06-08 | 2026-02-26 | 抗体結合ナノ粒子 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023531594A JP2023531594A (ja) | 2023-07-25 |
| JP2023531594A5 true JP2023531594A5 (enExample) | 2024-07-23 |
Family
ID=76971985
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022575309A Pending JP2023531594A (ja) | 2020-06-08 | 2021-06-07 | 抗体結合ナノ粒子 |
| JP2026029727A Pending JP2026102638A (ja) | 2020-06-08 | 2026-02-26 | 抗体結合ナノ粒子 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026029727A Pending JP2026102638A (ja) | 2020-06-08 | 2026-02-26 | 抗体結合ナノ粒子 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230233707A1 (enExample) |
| EP (1) | EP4161655A2 (enExample) |
| JP (2) | JP2023531594A (enExample) |
| CN (1) | CN116113401A (enExample) |
| AU (1) | AU2021286457A1 (enExample) |
| CA (1) | CA3180541A1 (enExample) |
| WO (1) | WO2021252327A2 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026128573A1 (en) * | 2024-12-12 | 2026-06-18 | University Of Washington | De novo designed tie2 mini binder acting as an agonist or antagonist for tie2 receptor |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2481231A1 (en) * | 2002-04-05 | 2003-10-23 | University Of Utah Research Foundation | Colon tumor specific binding peptides |
| US20090074711A1 (en) | 2006-09-07 | 2009-03-19 | University Of Southhampton | Human therapies using chimeric agonistic anti-human cd40 antibody |
| CA2909080C (en) * | 2013-04-11 | 2022-07-26 | Sunnybrook Research Institute | Methods, uses and compositions of tie2 agonists |
| WO2016010014A1 (ja) * | 2014-07-15 | 2016-01-21 | アステラス製薬株式会社 | 新規抗ヒトＴｉｅ２抗体 |
| GB2555131A (en) * | 2016-10-20 | 2018-04-25 | Imperial Innovations Ltd | Nanocage |
| US10818377B2 (en) * | 2016-11-16 | 2020-10-27 | University Of Washington | Computational design of self-assembling cyclic protein homo-oligomers |
| JOP20190100A1 (ar) | 2016-11-19 | 2019-05-01 | Potenza Therapeutics Inc | بروتينات ربط مولد ضد مضاد لـ gitr وطرق استخدامها |
-
2021
- 2021-06-07 CN CN202180057539.9A patent/CN116113401A/zh active Pending
- 2021-06-07 WO PCT/US2021/036117 patent/WO2021252327A2/en not_active Ceased
- 2021-06-07 EP EP21743312.7A patent/EP4161655A2/en active Pending
- 2021-06-07 US US18/000,004 patent/US20230233707A1/en active Pending
- 2021-06-07 AU AU2021286457A patent/AU2021286457A1/en active Pending
- 2021-06-07 JP JP2022575309A patent/JP2023531594A/ja active Pending
- 2021-06-07 CA CA3180541A patent/CA3180541A1/en active Pending
-
2026
- 2026-02-26 JP JP2026029727A patent/JP2026102638A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Leong et al. | Adapting pharmacokinetic properties of a humanized anti-interleukin-8 antibody for therapeutic applications using site-specific pegylation | |
| TWI250988B (en) | Thrombopoietic compounds | |
| EP2439212B1 (en) | Improved fibronectin-based binding molecules and uses thereof | |
| CN103180339B (zh) | 具有改善的稳定性的基于纤连蛋白的支架蛋白质 | |
| JP6486908B2 (ja) | 肝細胞増殖因子に結合する設計アンキリン反復タンパク質 | |
| CN102007145A (zh) | 基于结合egfr的工程化蛋白质的靶向治疗剂 | |
| CN102439036A (zh) | 双特异性egfr/igfir结合分子 | |
| JP2014504587A (ja) | Ｉｌ−２３に結合するフィブロネクチンをベースとするスカフォールドドメインタンパク質 | |
| RS51852B (sr) | Modifikovani peptidi kao terapeutski agensi | |
| CN107207623B (zh) | Fc融合高亲和力IgE受体α链 | |
| CN116675777B (zh) | 包含补体抑制结构域的多特异性配体结合分子及其用途 | |
| JP2023531594A (ja) | 抗体結合ナノ粒子 | |
| EP4438629A1 (en) | Multispecific ligand binding molecule and application thereof | |
| HUE035554T2 (en) | VEGF antagonist compositions and their uses | |
| CN116162148B (zh) | 多特异性配体结合分子及其应用 | |
| CN112194728B (zh) | 用于内毒素清除的嵌合抗原受体及其应用 | |
| US20250049731A1 (en) | Designed antibody-bound nanoparticles | |
| WO2022007885A1 (zh) | 融合多肽和多肽二聚体及其用途 | |
| HK40092774A (en) | Methods of using activin receptor type ii variants |